Anti-CD20 Monoclonal Antibodies (mABs) Market size to grow by USD 11.42 billion from 2023 to 2028; North America to account for 57% of market growth- Technavio

Source :: PR Newswire. November 9, 2023
Publication Year :: 2023
Abstract: NEW YORK, Nov. 9, 2023 /PRNewswire/ -- Thehttps://www.technavio.com/report/anti-cd20-monoclonal-antibodies-mabs-market-size-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=T2023_VRD_wk45_2023_019_rep&utm_content=IRTNTR71141 is expected to grow byUSD 11.42 billion from 2023 to 2028. In addition, the momentum of the market will progress at aCAGR [...]

Subjects :: Spectrum Pharmaceuticals Inc. -- Forecasts and trends
Amgen Inc. -- Forecasts and trends
Pfizer Inc. -- Forecasts and trends
Novartis AG -- Forecasts and trends
Regeneron Pharmaceuticals Inc. -- Forecasts and trends
AstraZeneca PLC -- Forecasts and trends
F. Hoffmann-La Roche Ltd. -- Forecasts and trends
Fosun International Ltd. -- Forecasts and trends
Biological products industry -- Forecasts and trends
Biotechnology industry -- Forecasts and trends
Health care industry -- Forecasts and trends
Investment companies -- Forecasts and trends
Monoclonal antibodies -- Growth
Pharmaceutical industry -- Forecasts and trends
Health care industry
Company growth
Market trend/market analysis
Business
News, opinion and commentary

Tools